doxorubicin hydrochloride

Generic: doxorubicin hydrochloride

Labeler: northstar rxllc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name doxorubicin hydrochloride
Generic Name doxorubicin hydrochloride
Labeler northstar rxllc
Dosage Form INJECTABLE, LIPOSOMAL
Routes
INTRAVENOUS
Active Ingredients

doxorubicin hydrochloride 2 mg/mL

Manufacturer
NorthStar RxLLC

Identifiers & Regulatory

Product NDC 72603-200
Product ID 72603-200_3d02b630-f667-47e6-b2d5-f7317b73df2e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA203263
Listing Expiration 2026-12-31
Marketing Start 2019-05-29

Pharmacologic Class

Classes
anthracycline topoisomerase inhibitor [epc] anthracyclines [cs] topoisomerase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72603200
Hyphenated Format 72603-200

Supplemental Identifiers

RxCUI
1790115 1790127
UPC
0372603200010
UNII
82F2G7BL4E

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name doxorubicin hydrochloride (source: ndc)
Generic Name doxorubicin hydrochloride (source: ndc)
Application Number ANDA203263 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 2 mg/mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-DOSE in 1 PACKAGE (72603-200-01) / 25 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (1)

72603-200-01 1 VIAL, SINGLE-DOSE in 1 PACKAGE (72603-200-01) / 25 mL in 1 VIAL, SINGLE-DOSE

Ingredients (1)

doxorubicin hydrochloride (2 mg/mL)

Linked Drug Pages (1)

Doxorubicin Hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "3d02b630-f667-47e6-b2d5-f7317b73df2e", "openfda": {"upc": ["0372603200010"], "unii": ["82F2G7BL4E"], "rxcui": ["1790115", "1790127"], "spl_set_id": ["ddf55319-bf62-4ec7-8be2-ef97188837c4"], "manufacturer_name": ["NorthStar RxLLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 PACKAGE (72603-200-01)  / 25 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "72603-200-01", "marketing_start_date": "20190529"}], "brand_name": "Doxorubicin Hydrochloride", "product_id": "72603-200_3d02b630-f667-47e6-b2d5-f7317b73df2e", "dosage_form": "INJECTABLE, LIPOSOMAL", "pharm_class": ["Anthracycline Topoisomerase Inhibitor [EPC]", "Anthracyclines [CS]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "72603-200", "generic_name": "Doxorubicin Hydrochloride", "labeler_name": "NorthStar RxLLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Doxorubicin Hydrochloride", "active_ingredients": [{"name": "DOXORUBICIN HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "ANDA203263", "marketing_category": "ANDA", "marketing_start_date": "20190529", "listing_expiration_date": "20261231"}